b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">28681958</PMID>\n        <DateCompleted>\n            <Year>2017</Year>\n            <Month>10</Month>\n            <Day>10</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2017</Year>\n            <Month>12</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1521-4141</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>47</Volume>\n                    <Issue>9</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                        <Month>09</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>European journal of immunology</Title>\n                <ISOAbbreviation>Eur. J. Immunol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1488-1500</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/eji.201646860</ELocationID>\n            <Abstract>\n                <AbstractText>CD4<sup>+</sup> T cells differentiate into distinct effector subsets upon antigenic stimulation. Cytokines, and micro-environmental factors present during T-cell priming, direct differentiation of na\xc3\xafve CD4<sup>+</sup> T cells into pro-inflammatory Th1 and Th17 cells. From extensive screening of 2,4,5-trimethylpyridin-3-ol derivatives with various functional groups at C(6)-position, BJ-2266, a 6-thioureido-derivative, showed potent inhibitory activity on in vitro T helper (Th)-cell differentiation. This compound inhibited IFN-\xce\xb3 and IL-17 production from polyclonal CD4<sup>+</sup> T cells and ovalbumin (OVA)-specific CD4<sup>+</sup> T cells that were activated by T-cell receptor (TCR) engagement. We assessed the inhibitory effect of BJ-2266 in experimental autoimmune encephalomyelitis (EAE). Our results suggest that BJ-2266 treatment significantly suppresses EAE disease progression with reduced generation of Th1 and Th17 cells. Notably, Th-cell differentiation was significantly suppressed by BJ-2266 treatment with no effect on apoptosis, activation and proliferation of activated T cells. Furthermore, adoptive transfer of BJ-2266 treated MOG-reactive Th1 and Th17 cells led to a lower EAE disease score and better clinical recovery from EAE. The underlying mechanism of BJ-2266 effect involved the inhibition of JAK/STAT phosphorylation that is critical for Th-cell differentiation. We conclude that BJ-2266 regulates the JAK/STAT pathway in response to cytokine signals and subsequently suppresses the differentiation of Th-cell responses.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2017 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>You</LastName>\n                    <ForeName>Zhiwei</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Timilshina</LastName>\n                    <ForeName>Maheshwor</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jeong</LastName>\n                    <ForeName>Byeong-Seon</ForeName>\n                    <Initials>BS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chang</LastName>\n                    <ForeName>Jae-Hoon</ForeName>\n                    <Initials>JH</Initials>\n                    <Identifier Source="ORCID">0000-0002-1001-6570</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>07</Month>\n                <Day>26</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Eur J Immunol</MedlineTA>\n            <NlmUniqueID>1273201</NlmUniqueID>\n            <ISSNLinking>0014-2980</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000631">Aminopyridines</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000623230">BJ-2266</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001549">Benzamides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D050791">STAT Transcription Factors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>268B43MJ25</RegistryNumber>\n                <NameOfSubstance UI="D014527">Uric Acid</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>7F23ZQP3EM</RegistryNumber>\n                <NameOfSubstance UI="C010352">6-thiouric acid</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>82115-62-6</RegistryNumber>\n                <NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.10.2</RegistryNumber>\n                <NameOfSubstance UI="D053612">Janus Kinases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>GYV9AM2QAG</RegistryNumber>\n                <NameOfSubstance UI="D013890">Thiourea</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000631" MajorTopicYN="N">Aminopyridines</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004681" MajorTopicYN="N">Encephalomyelitis, Autoimmune, Experimental</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053612" MajorTopicYN="N">Janus Kinases</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D050791" MajorTopicYN="N">STAT Transcription Factors</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058504" MajorTopicYN="N">Th17 Cells</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013890" MajorTopicYN="N">Thiourea</DescriptorName>\n                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014527" MajorTopicYN="N">Uric Acid</DescriptorName>\n                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Adoptive transfer EAE</Keyword>\n            <Keyword MajorTopicYN="Y">Differentiation</Keyword>\n            <Keyword MajorTopicYN="Y">IFN-\xce\xb3</Keyword>\n            <Keyword MajorTopicYN="Y">IL-17</Keyword>\n            <Keyword MajorTopicYN="Y">JAK/STAT</Keyword>\n            <Keyword MajorTopicYN="Y">MOG peptide</Keyword>\n            <Keyword MajorTopicYN="Y">Th1/Th17 cell</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2016</Year>\n                <Month>12</Month>\n                <Day>07</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>05</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>07</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>7</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>7</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">28681958</ArticleId>\n            <ArticleId IdType="doi">10.1002/eji.201646860</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'